Additionally, LEC-released chemokines increased lymphatic invasion by upregulating VE-cadherin phosphorylation and junction disruption, which in turn increased serum amyloid A1 (SAA1) expression in breast cancer cells (96). This evidence concerns the gene SAA1 and breast carcinoma.